SCHEMBL24499466

SCHEMBL24499466

CC1COc2ccccc2N1C(=O)c1cncc(Cl)n1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.67
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
HSD11B1 P28845 1/20 0.47
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
HCRTR2 O43614 1/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
RAB9A P51151 1/20 0.40
ALOX15 P16050 1/20 0.38
GRM5 P41594 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24499502 0.81 MEN1 (0.63) MAPTMEN1KMT2AHSD11B1CRHBP
SCHEMBL24499469 0.78 PDK1 (0.57) MEN1KMT2AALDH1A1GAASMN1; SMN2
SCHEMBL24499507 0.75 POLB (0.58) TP53POLBL3MBTL1
SCHEMBL16144910 0.75 MEN1 (0.67) MAPTMEN1KMT2AHSD11B1CRHBP
SCHEMBL13767851 0.73 MEN1 (0.64) MAPTMEN1KMT2AHSD11B1CRHBP
SCHEMBL4894293 0.73 MEN1 (0.72) MAPTMEN1KMT2AHSD11B1CRHBP
Benoxacor SCHEMBL122820 0.71 ALDH1A1 (0.67) MAPTMEN1KMT2AHSD11B1CRHBP
Benoxacor SCHEMBL3674598 0.71 ALDH1A1 (0.67) MAPTMEN1KMT2AHSD11B1CRHBP
Benoxacor SCHEMBL29419104 0.71 ALDH1A1 (0.67) MAPTMEN1KMT2AHSD11B1CRHBP
Benoxacor SCHEMBL29963816 0.71 ALDH1A1 (0.67) MAPTMEN1KMT2AHSD11B1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022117920-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER ORION CORPORATION (FI) 2022-06-09 WO disclosed